Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.
Press releases published on May 8, 2025
AnswersNow Named Best Telehealth Platform in 2025 MedTech Breakthrough Awards
GlobeNewswire
·
May 8, 2025
RICHMOND, Va., May 08, 2025 (GLOBE NEWSWIRE) -- AnswersNow, the leader in virtual Applied Behavioral Analysis (ABA) therapy, today announced that it was named Best Telehealth Platform for 2025 by the MedTech Breakthrough Awards. AnswersNow was recognized …
Alpha Pro Tech, Ltd. Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Net sales for the first quarter of 2025 were $13.8 million, up 2.5%, compared to $13.5 million for the first quarter of 2024 Building Supply segment sales increased by $132,000 or 1.6%, to $8.4 million, compared to $8.2 million for the three months ended …
LiveWorld Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
CAMPBELL, Calif. and NEW YORK , May 08, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for first quarter 2025. Three Months 2025 Financial and Business Highlights Total three months revenues of $2.6 million …
Wellgistics Health Secures $50M ELOC facility for XRP Treasury Reserve & Real-Time Payments Infrastructure and other general ops
GlobeNewswire
·
May 8, 2025
Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based …
United-Guardian Reports First Quarter Results
GlobeNewswire
·
May 8, 2025
HAUPPAUGE, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the first quarter of 2025. First quarter sales decreased from $3,254,944 in 2024 to $2,481,127 in 2025, with net income decreasing …
Dogwood Therapeutics Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
- Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Study - - Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b study interim data readout is expected in Q4 2025 - - Cash on …
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
GlobeNewswire
·
May 8, 2025
Southlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier …
Oklahoma City Community College commencement May 17 to feature four ceremonies, speakers
GlobeNewswire
·
May 8, 2025
OKLAHOMA CITY, May 08, 2025 (GLOBE NEWSWIRE) -- Oklahoma City Community College (OCCC) will honor more than 1,900 graduates during 2025 commencement exercises on Saturday, May 17. Four ceremonies — 10 a.m., 1 p.m., 4 p.m. and 7 p.m. — will be held in the …
Edible Garden Schedules First Quarter 2025 Financial Results and Business Update Conference Call
GlobeNewswire
·
May 8, 2025
BELVIDERE, NJ, May 08, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, …
Best Steroids For Cutting: Top Anabolic Steroid Stack For Cutting Cycles To Get Ripped And Shredded Muscles - Crazybulk
GlobeNewswire
·
May 8, 2025
New York City, May 08, 2025 (GLOBE NEWSWIRE) -- When individuals commit to bodybuilding, they often find adding mass relatively straightforward. However, they encounter a significant challenge during the cutting phase due to its demanding nature and the …
Best Legal Steroids (USA): Top 4 Anabolic Steroids For Muscle Growth & Natural Bodybuilding By Wolfson Brands
GlobeNewswire
·
May 8, 2025
Glasgow, May 08, 2025 (GLOBE NEWSWIRE) -- Introduction: Legal Steroids – The Safer Path to Muscle Growth In the world of bodybuilding and fitness, the pursuit of muscle growth, strength, and a shredded physique often leads people to explore supplements …
AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists
GlobeNewswire
·
May 8, 2025
OCALA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (OTC Pink: AIMI) (“AIM” or the “Company”) today announced the presentation of clinical trial data involving AIM’s drug Ampligen by Pawel Kalinski, MD, PhD, at the recent …
GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
GlobeNewswire
·
May 8, 2025
The Independent Data Monitoring Committee (IDMC) has recommended to continue the study as planned as there are no safety concerns seen in the data reviewed Continued momentum with completed patient enrollment for the 6-week interim analysis (N=24) and over …
Senti Bio Releases Mechanism of Action Video for First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202
GlobeNewswire
·
May 8, 2025
Access video here SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its …
Vor Bio Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
GlobeNewswire
·
May 8, 2025
CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, based on currently available clinical data from its key clinical programs and a challenging fundraising …
HepaRegeniX Scientific Founder Covers HRX-215 Development and Clincial Data in Plenary at the European Association for the Study of the Liver Congress 2025
GlobeNewswire
·
May 8, 2025
Prof. Lars Zender’s featured talk described HepaRegeniX’s lead candidate and its potential in increasing liver regeneration, from initial target discovery and drug development towards Phase Ia clinical trial results Tuebingen, Germany, May 8, 2025 – …
Adial Pharmaceuticals Granted End of Phase 2 Meeting from the U.S. Food and Drug Administration
GlobeNewswire
·
May 8, 2025
Meeting to Take Place on July 25, 2025 Meeting’s Purpose is To Discuss Upcoming Clinical Development Plan and Protocol Designs GLEN ALLEN, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a …
Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset
GlobeNewswire
·
May 8, 2025
New patent filing secures composition of matter protection for AZD5904, a potent myeloperoxidase inhibitor in Conduit’s pipeline, unlocking up to 20 years of new IP runway and enabling enhanced formulation strategies to target a broad range of diseases. …
Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons
GlobeNewswire
·
May 8, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
Exagen Inc. Prices Public Offering of Common Stock
GlobeNewswire
·
May 8, 2025
CARLSBAD, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced the pricing of its previously announced underwritten public offering of 3,350,000 shares of its common stock …